Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Is CMS Pay Policy Hindering Flow of IVIG To Patients?

May 31, 2007

By Aaron Lorenzo

BioMarin Submits NDA For Phenylketonuria Drug Kuvan

May 25, 2007

By Aaron Lorenzo

BioMarin Submits NDA For Phenylketonuria Drug Kuvan

May 25, 2007

By Aaron Lorenzo

Pivotal PolyHeme Trial Fails To Hit Endpoints, Hurting Northfield

May 24, 2007

By Aaron Lorenzo

Vion Halts Phase III AML Trial, Causing Stock Drop

May 24, 2007

By Aaron Lorenzo

Pivotal PolyHeme Trial Fails To Hit Endpoints, Hurting Northfield

May 24, 2007

By Aaron Lorenzo

Vion Halts Phase III AML Trial, Causing Stock Drop

May 24, 2007

By Aaron Lorenzo

Orexigen Starts Second Of Four Phase III Trials Of Obesity Drug

May 23, 2007

By Aaron Lorenzo

FDA Panelists Cast Favorable Votes For Smallpox Vaccine

May 23, 2007

By Aaron Lorenzo

FDA Panelists Cast Favorable Votes For Smallpox Vaccine

May 23, 2007

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 2, 2025
Ionis notches Arrowhead win; Tryngolza cleared for FCS
BioWorld
Ionis Pharmaceuticals Inc. CEO Brett Monia predicted that diagnoses of familial chylomicronemia syndrome (FCS) will “accelerate fairly quickly” now that the firm...
NRP1 is NGF/TrkA partner in crime in pain signaling
BioWorld Science
Chronic pain affects about 20% of the population worldwide. It is – inadequately – treated with nonsteroidal anti-inflammatory compounds and opioids that lack...
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.